The Pharmaceutical Pellets Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Pharmaceutical Pellets Market:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-pellets-global-market-report
According to The Business Research Company’s Pharmaceutical Pellets Global Market Report 2024, The pharmaceutical pellets market size has grown rapidly in recent years. It will grow from $1.66 billion in 2023 to $1.86 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to rise in oral dosage forms, focus on patient compliance, pharmaceutical research initiatives, efforts for taste-masking and stability, regulatory approvals and patents.
The pharmaceutical pellets market size is expected to see rapid growth in the next few years. It will grow to $2.82 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increased demand for pediatric dosage forms, demand for multi-particulate dosage forms, development of combination therapy dosage forms, advances in continuous manufacturing, focus on geriatric dosage forms. Major trends in the forecast period include integration of 3d printing technologies, application in personalized nutrition, smart coatings for real-time monitoring, orally disintegrating pellets, biodegradable and eco-friendly pellets.
The increasing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical pellets market going forward. Chronic diseases are defined as problems that last for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. The use of pharmaceutical pellets can be beneficial for the treatment of chronic diseases as they reduce digestive problems and enhance drug absorption. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, by 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the increasing prevalence of chronic diseases is driving the growth of the pharmaceutical pellets market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12354&type=smp
The pharmaceutical pellets market covered in this report is segmented –
1) By Technology: Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution And Suspension Layering, Spray Congealing, Spray Drying
2) By Mechanism Of Action: Diffusion, Erosion, Osmosis
3) By Technique: Direct, Melt, Wet, Dry
4) By End-User: Pharmaceutical, Nutraceutical
Product innovation is a key trend gaining popularity in the pharmaceutical pellets market. Companies operating in the pharmaceutical pellets market are focused on innovating new products to sustain their position in the market. For instance, in June 2021, Gilead Sciences Inc., a US-based biopharmaceutical company, received approval for the oral pellet version of Epclusa from the U.S. Food and Drug Administration. It is used for children who have a chronic hepatitis C infection. To improve the tolerability associated with palatability, oral pellets are administered once a day with food.
The pharmaceutical pellets market report table of contents includes:
1. Executive Summary
- Market Characteristics
- Market Trends And Strategies
- Impact Of COVID-19
- Market Size And Growth
- Segmentation
- Regional And Country Analysis
……..
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
